CRChristine Rini

Christine Rini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christine Rini has a total of 470 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluating a Tailored Web-Based eHealth Intervention for Symptom Management in Couples Managing Prostate Cancer During the COVID-19 Pandemic: Randomized Clinical Trial

    by Lixin Song, Christine Rini, Yuexia Zhang, Chunxuan Ma, Laurel Northouse, Matthew E Nielsen, Xianming Tan, Ronald C Chen

    Background: Prostate cancer (PCa) is the most common nonskin cancer among men. Although treatments achieve excellent survival for localized PCa, long-lasting complications significantly diminish patients’ quality of life (QOL) across physical, sexual, psychosocial, and general symptom domains. Because these effects also profoundly impact intimate partners, often reducing partners’ QOL as much as or more than patients’ QOL, supportive care must address the needs of both members of the couple. Objective: This study evaluated the efficacy of the Prostate Cancer Education and Resources for Couples (PERC) eHealth intervention in improving outcomes for patients and their partners. Methods: We enrolled 280 dyads (560 individuals) consisting of patients with localized PCa who recently completed treatment and their partners through the North Carolina Cancer Registry. Dyads were randomized to PERC or a control group that received access to the National Cancer Institute prostate cancer website. PERC dyads completed a nurse-led orientation and received monthly follow-ups. The platform has the following three components: (1) 11 interactive modules with postsession assignments on QOL, symptom management, and cancer communication; (2) a moderated online forum providing professional and peer support; and (3) a resource toolbox containing scientific publications related to PCa care. PERC development was guided by an adapted stress-coping theory and informed by evidence and stakeholder input. Validated questionnaires assessed QOL (Functional Assessment of Chronic Illness Therapy–General [FACT-G] total; primary outcomes), FACT-G subdomains, and symptom and psychosocial measures (secondary outcomes) at baseline and at 4, 8, and 12 months. Multilevel linear mixed models tested intervention effects. Results: The trial was conducted during the COVID-19 pandemic. Among PERC (n=141) and control (n=139) dyads who completed baseline assessments, 221 (78.9%) dyads completed the 12-month follow-up (PERC=106 and control=115). FACT-G total score, subdomains, and overall psychosocial outcomes did not differ significantly between groups over time. Patients assigned to PERC reported better physical QOL (mean difference 0.9, 95% CI –0.1 to 1.9; Cohen d =0.33), less negative illness appraisal (mean difference 0.2, 95% CI 0.0-0.4; Cohen d =0.38), lower pain (mean difference –2.7, 95% CI –5.3 to –0.2; Cohen d =–0.38) at 12 months, and less frequent fatigue across time (mean difference –2.1, –95% CI –3.9 to –0.4; Cohen d =–0.23). PERC partners reported less urinary symptom bother at 8 months (mean difference 6.5, 95% CI –1.0 to 14.1; Cohen d =0.44). Conclusions: Although no significant between-group difference was observed in the FACT-G total score, PERC demonstrated exploratory benefits, including improved physical QOL, less fatigue, lower pain, and improved illness appraisal among patients, as well as less urinary bother among partners. These findings suggest that the COVID-19 pandemic may have adversely affected participants’ overall QOL, potentially obscuring changes in the primary outcome, while highlighting targeted benefits that warrant evaluation in larger studies.

  • Effects of expressive helping writing during stem cell transplant: Randomized controlled trial.

    by Christine Rini, George Luta, Deniz Ozisik, Scott D. Rowley, Annette L. Stanton, Heiddis Valdimarsdottir, Jane Austin, Betina Yanez, Kristi D. Graves

    Most cancer patients undergoing hematopoietic stem cell transplant report elevated symptoms and reduced health-related quality of life during peritransplant. These concerns can become persistent. A prior randomized controlled trial showed that expressive helping-a low-burden, brief intervention combining expressive writing with a novel peer support writing exercise-reduced psychological distress and physical symptoms in long-term transplant survivors with moderate/high persistent symptoms. The Writing for Insight, Strength, and Ease trial evaluated the use of expressive helping during peritransplant, when symptoms peak and early intervention could prevent the development of persistent symptoms. Three hundred sixty-six adult blood cancer patients (44.3% female, 74.6% White, 13.4% Black, 11.5% Hispanic/Latinx) scheduled for allogeneic (33.9%) or autologous (66.1%) transplant were randomized to complete either expressive helping or a neutral writing task in four writing sessions beginning pretransplant and ending 4 weeks posthospital discharge. Symptom severity (primary outcome), distress (depressive symptoms, generalized and cancer-specific anxiety), health-related quality of life, and fatigue were measured in multiple assessments from prerandomization to 12 months postintervention. Primary endpoints at 3 and 12 months postintervention estimated short- and long-term intervention effects. Moderation analyses explored subgroup differences in intervention efficacy. Mixed models with repeated measures analyses revealed no statistically or clinically significant intervention effects on primary or secondary outcomes. Moderation analyses did not identify subgroups of participants who benefitted from the intervention. Findings do not support use of expressive helping during peritransplant. We recommend that survivors with persistent symptoms complete expressive helping at least 9 months posttransplant, consistent with evidence from a prior trial. (PsycInfo Database Record (c) 2025 APA, all rights reserved).


  • How people undergoing genomic sequencing interpret and react to varied secondary findings with limited actionability

    by Haoyang Yan, Christine M. Rini, Ann Katherine M. Foreman, Jonathan S. Berg, Gail E. Henderson, Kristy Lee, Julianne M. O’dAniel, Myra Roche, Margaret Waltz

    To investigate patient reactions to and understanding of secondary genomic findings with limited to no medical actionability (LMA-SFs) from diagnostic genome sequencing. We analyzed LMA-SFs returned to 47 adults who elected to receive a broad set of these results from 6 categories. Findings indicated elevated risk (reportable/positive) or not (negative/normal). Most participants (N = 43) also completed surveys to report their distress, decision regret, expected health anxiety, and whether and how they perceived results as reassuring or troubling. Most participants received some reportable LMA-SFs for common risk, pharmacogenetic, and carrier status variants. Fewer received reportable APOE haplotype or monogenetic condition variants. None received results indicating high risk for severe neurological disease. Overall, participants (76.7% female, 97.7% White) had low distress, decision regret, and expected health anxiety. None described negative/normal findings as troubling. However, their interpretations of reportable/positive results varied. Even within the same result type, some participants found them troubling, while others found them reassuring based on their perception of the results' utility. Participants' short-term well-being was not reduced by receiving LMA-SFs. Their interpretations suggested varied personal utilities and the need for post-test resources to aid understanding of these types of results and their health significance.


  • Web-Based Pain Coping Skills Training (PCST) for Managing Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors: Randomized Controlled Trial Protocol

    by Zahra Hosseinian, Ashley Lehan, Jessica M. Powers, Adrian Melendez, Hannah M. Fisher, Rebecca Shelby, Tamara Somers, Francis Keefe, Judith Paice, Gretchen Kimmick, et al.


  • Group-based medical mistrust in genomic medicine: Associations with patient and provider perceptions of a specialty clinical encounter

    by Frank Angelo, Margaret Waltz, Haoyang Yan, Jonathan S. Berg, Ann Katherine M. Foreman, Julianne O’daniel, Christine Rini


  • Open Access

    Medical Advocacy among Latina Women Diagnosed with Breast Cancer

    by Paola Torres, Judith Guitelman, Araceli Lucio, Christine Rini, Yamilé Molina

    Medical advocacy has continued to significantly impact quality of life and survivorship outcomes among Latina breast cancer survivors in the United States. However, little is known about the unique experiences of Latina survivors, including the perceived value, process, and context in which they practice medical advocacy. To help address this gap, we conducted a qualitative, secondary analysis of semi-structured focus groups with 18 Latina breast cancer survivors from Chicago, Illinois. Eligible women had to self-identify as (1) female, (2) Latina, (3) 18 years or older, and (4) having a breast cancer diagnosis 5 years ago or more. In total, 61% of participants were 50–59 years old, 83% were born in Mexico, and 100% spoke Spanish. The three emergent themes from the focus groups were (1) the cultural need for Latina advocates and support groups; (2) the process and experiences of becoming a community advocate within Latine culture; and (3) the cultural contexts for advocacy by Latina breast cancer survivors. Latina survivor advocates share strengths of receiving ongoing health education, peer support, and access to resources when being linked to a support group furthering their exposure to role models, increasing their awareness of opportunities in medical advocacy, and providing an entry to participate in medical advocacy.


  • Greater Social Isolation and Social Constraints Prior to Hematopoietic Stem Cell Transplant Are Associated with Greater Anxiety and Depressive Symptoms

    by Layan Shahrour, Joseph Martinez, Anthony Chicaiza, Rahma Omar, Katrin Bovbjerg, Annette L. Stanton, Heiddis Valdimarsdottir, Betina Yanez, Pashna Munshi, Scott D. Rowley, et al.

    Background Hematopoietic stem cell transplantation (hereafter “HCT”) is a physically and psychologically difficult treatment for patients with hematological cancers. This study examined relationships among patients’ reports of pre-transplant social isolation, social constraints, and psychological distress. Method We used baseline data from a multisite randomized controlled trial evaluating the effects of expressive helping writing to reduce physical and emotional symptoms in HCT patients. We collected data prior to randomization and before either allogenic or autologous HCT using validated scales to assess social constraints, social isolation, anxiety, and depressive symptoms. We analyzed data using bivariate analysis and multivariate linear regression. We also explored whether social isolation mediated the effect of social constraints on both of our outcomes: anxiety and depressive symptoms. Results Among 259 adults recruited prior to transplant, 43.6% were women (mean age = 57.42 years, SD = 12.34 years). In multivariate analysis controlling for relevant covariates, both social isolation (β = 0.24, p < 0.001) and social constraints (β = 0.28, p < 0.001) were associated with anxiety. When both social constraints and social isolation were in the model, only greater social isolation (β = 0.79, p < 0.001) was associated with depressive symptoms. Social isolation fully mediated the association between social constraints and anxiety and depressive symptoms. Conclusion For patients awaiting either allogenic or autologous HCT, the negative association between social constraints and anxiety and depressive symptoms may be related, in part, to the mechanism of perceived social isolation. Interventions prior to and during HCT are needed to support patients’ psychological health and sense of social connectedness.


  • Open Access

    The Challenges and Strategies of Accrual and Retention During COVID-19 in a Randomized Controlled Trial Testing A Dyad-focused eHealth Intervention (Preprint)

    by Chunxuan Ma, Rachel H. Adler, Daria B. Neidre, Ronald C. Chen, Laurel L. Northouse, Christine Rini, Xianming Tan, Lixin Song

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Family-based randomized controlled trials (RCT) encounter recruitment and retention challenges. Cancer-focused RCTs typically recruit convenience samples from local cancer centers and hospitals. Objective: Our study examined the recruitment and retention of a population-based patient-partner dyad cohort in an RCT testing a dyadic eHealth intervention to improve quality of life in prostate cancer (PCa) patients and their partners. Methods: In this two-arm, parallel-group RCT, men who recently completed treatment for localized PCa statewide were recruited via the North Carolina Central Cancer Registry Rapid Case Ascertainment (RCA) between April 2018 and April 2021, coinciding with the COVID-19 pandemic. Patient-partner dyads underwent baseline assessments and were randomly assigned to the intervention or control groups. Follow-up surveys were conducted at 4-, 8-, and 12 months post-baseline. Descriptive and logistic regression analyses were employed to achieve the study’s aims. Results: Of the 3,078 patients referred from RCA, 2,899 were screened; 357 partners were approached after obtaining eligible patients’ permission; 280 dyads completed baseline assessments and randomized (dyad enrollment rate: 85.11%); and 221 dyads completed the 12-month follow-up (retention rate: 78.93%). Factors associated with retention included race and age. Conclusions: Despite the negative impact of the pandemic, we successfully recruited enough patient-partner dyads to test our RCT hypotheses. Our recruitment and retention rates were equivalent to or higher than those in most dyadic intervention studies. A well-functioning research team and specific strategies (e.g., eHealth intervention, Internet phone, and online surveys) facilitated the recruitment and retention of PCa patients and their partners during the unprecedented pandemic. Clinical Trial: Clinicaltrial.gov ID: NCT03489057.


  • Open Access

    Challenges and Approaches to Recruitment for and Retention in a Dyad-Focused eHealth Intervention During COVID-19: Randomized Controlled Trial (Preprint)

    by Chunxuan Ma, Rachel H Adler, Daria B Neidre, Ronald C Chen, Laurel L Northouse, Christine Rini, Xianming Tan, Lixin Song

    BACKGROUND Family-based randomized controlled trials (RCTs) encounter recruitment and retention challenges. Cancer-focused RCTs typically recruit convenience samples from local cancer centers and hospitals. OBJECTIVE This study aimed to examine the recruitment and retention of a population-based, patient-partner dyad cohort in an RCT testing a dyadic eHealth intervention to improve the quality of life in patients with prostate cancer and their partners. METHODS In this 2-arm, parallel-group RCT, men who recently completed treatment for localized prostate cancer statewide were recruited through North Carolina Central Cancer Registry rapid case ascertainment between April 2018 and April 2021, coinciding with the COVID-19 pandemic. Patient-partner dyads underwent baseline assessments and were randomly assigned to either the intervention or control groups. Follow-up surveys were conducted at 4, 8, and 12 months after baseline. Descriptive and logistic regression analyses were used to achieve the study’s aims. RESULTS Of the 3078 patients referred from rapid case ascertainment, 2899 were screened. A total of 357 partners were approached after obtaining the eligible patients’ permission, 280 dyads completed baseline assessments and were randomized (dyad enrollment rate: 85.11%, 95% CI 81.3%-88.9%), and 221 dyads completed the 12-month follow-up (retention rate: 78.93%, 95% CI 74.2%-83.7%). Regarding the factors associated with retention, compared with White participants, people self-reporting as “other races” (including American Indian, Asian, and multiracial) were more likely to drop out of the study (odds ratio 2.78, 95% CI 1.10-7.04), and older participants were less likely to withdraw (odds ratio 0.96, 95% CI 0.92-0.99). CONCLUSIONS Despite the negative impact of the pandemic, we successfully recruited enough patient-partner dyads to test our RCT hypotheses. Our recruitment and retention rates were equivalent to or higher than those in most dyadic intervention studies. A well-functioning research team and specific strategies (eg, eHealth intervention, internet phone, and online surveys) facilitated the recruitment and retention of patients with prostate cancer and their partners during the unprecedented pandemic. CLINICALTRIAL ClinicalTrials.gov NCT03489057; https://clinicaltrials.gov/study/NCT03489057 INTERNATIONAL REGISTERED REPORT RR2-https://doi.org/10.1186/s13063-021-05948-5

  • Open Access

    Physical activity maintenance among young adult cancer survivors in an mHealth intervention: Twelve‐month outcomes from the IMPACT randomized controlled trial

    by Carmina G. Valle, Molly A. Diamond, Hillary M. Heiling, Allison M. Deal, Derek P. Hales, Brooke T. Nezami, Jessica Gokee LaRose, Christine M. Rini, Bernardine M. Pinto, Deborah F. Tate

    Background: Most physical activity (PA) interventions in young adult cancer survivors (YACS) have focused on short‐term outcomes without evaluating longer‐term outcomes and PA maintenance. This study examined the effects of an mHealth PA intervention at 12 months, after 6 months of tapered contacts, relative to a self‐help group among 280 YACS.Methods: YACS participated in a 12‐month randomized trial that compared self‐help and intervention groups. All participants received an activity tracker, smart scale, individual videochat session, and access to a condition‐specific Facebook group. Intervention participants also received lessons, tailored feedback, adaptive goal setting, text messages, and Facebook prompts for 6 months, followed by tapered contacts. Accelerometer‐measured and self‐reported PA (total [primary outcome], moderate‐to‐vigorous [MVPA], light, steps, sedentary behaviors) were collected at baseline, 6, and 12 months. Generalized estimating equation analyses evaluated group effects on outcomes from baseline to 12 months.Results: From baseline to 12 months, there were no between‐ or within‐group differences in accelerometer‐measured total PA min/week, while increases in self‐reported total PA were greater in the intervention versus self‐help group (mean difference = +55.8 min/week [95% CI, 6.0–105.6], p = 0.028). Over 12 months, both groups increased accelerometer‐measured MVPA (intervention: +22.5 min/week [95% CI, 8.8–36.2] vs. self‐help: +13.9 min/week [95% CI, 3.0–24.9]; p = 0.34), with no between‐group differences. Both groups maintained accelerometer‐measured and self‐reported PA (total, MVPA) from 6 to 12 months. At 12 months, more intervention participants reported meeting national PA guidelines than self‐help participants (47.9% vs. 33.1%, RR = 1.45, p = 0.02).Conclusion: The intervention was not more effective than the self‐help group at increasing accelerometer‐measured total PA over 12 months. Both groups maintained PA from 6 to 12 months. Digital approaches have potential for promoting sustained PA participation in YACS, but additional research is needed to identify what strategies work for whom, and under what conditions.